Based on these findings, the adiponectin gene variant, or a mutation in linkage with it, determines lower levels of adiponectin protein expression, which in turn increases the risk of developing insulin resistance, atherosclerosis, and cardiovascular disease. This evidence concerns the gene ADIPOQ and cardiovascular disorder.